25 LLC’s Elevance Health ELV Stock Holding History

25 LLC’s Portfolio ELV Stock Details ELV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-2	Closed	-$836	–	186
2023 Q2	$836	Hold	2	–	–	﹤0.01%	315
2023 Q1	$931	Buy	+2	New	+$952	﹤0.01%	240

Other funds holding ELV

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Sanders Capital West Palm Beach, Florida $83.9B AUM 37.89% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

25 LLC's ELV Position: Q3 2023 in Review

25 LLC sold out of Elevance Health (ELV) in Q3 2023, closing a stake of 2 shares — an estimated $836 sold.

25 LLC first reported a position in ELV in Q1 2023 and held it in 2 quarters. The position peaked at $931 in Q1 2023. 1,523 funds tracked by Wall St. Rank hold ELV as of Q3 2023.

25 LLC reported no remaining Elevance Health position as of Q3 2023 after selling out during the quarter.
25 LLC sold 2 Elevance Health shares in Q3 2023, an estimated $836.
25 LLC first reported a position in Elevance Health in Q1 2023 and held it in 2 quarters.
25 LLC's Elevance Health position peaked at $931 in Q1 2023.
1,523 funds tracked by Wall St. Rank held Elevance Health as of Q3 2023.

Based on 25 LLC's 13F filing for Q3 2023, filed 18 Oct 2023.